Clinical Trials

Can Gen AI Foster Ethical Progress in Biopharma?
Tech & Innovation Can Gen AI Foster Ethical Progress in Biopharma?

In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured

Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?
Management & Regulatory Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?

To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By

How Will Matinas BioPharma's $10M Direct Offering Impact Its Future?
Management & Regulatory How Will Matinas BioPharma's $10M Direct Offering Impact Its Future?

Strategic Financial Undertaking by Matinas BioPharma Matinas BioPharma Holdings, Inc. has embarked on a crucial growth plan with its recent $10 million direct offering. Such a financial move is a testament to the company's dedication to securing necessary capital for advancement. The offering

Navigating International Data Privacy in Clinical Trials
Management & Regulatory Navigating International Data Privacy in Clinical Trials

Global clinical research adheres to an intricate framework of laws and regulations, challenging organizations and researchers to remain in compliance. With the rise of the GDPR, understanding and navigating the complexities of international data privacy is now an integral part of conducting

YS Biopharma's New Rabies Vaccine Shows Promise in Phase III Trial
Management & Regulatory YS Biopharma's New Rabies Vaccine Shows Promise in Phase III Trial

Rabies continues to pose a major public health issue worldwide, but YS Biopharma is breaking new ground with its PIKA Rabies Vaccine. This vaccine has delivered promising results during its Phase III clinical trials. The innovation lies in the company's unique PIKA adjuvant technology, which

How Is Exblifep Reinventing UTI and Pneumonia Treatment?
Management & Regulatory How Is Exblifep Reinventing UTI and Pneumonia Treatment?

The realm of antibiotic therapy is witnessing a remarkable transformation with the UK's MHRA's endorsement of Exblifep, a novel medical intervention for the management of sophisticated urinary tract infections (UTIs) and select instances of pneumonia. Originating from Advanz Pharma's

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later